WB | 咨询技术 | Human,Mouse,Rat |
IF | 咨询技术 | Human,Mouse,Rat |
IHC | 1/50-1/100 | Human,Mouse,Rat |
ICC | 1/100-1/300 | Human,Mouse,Rat |
FCM | 咨询技术 | Human,Mouse,Rat |
Elisa | 咨询技术 | Human,Mouse,Rat |
Aliases | C20orf74; KIAA1272; Ral GTPase-activating protein subunit alpha-2; 250 kDa substrate of Akt; AS250; p220 |
Entrez GeneID | 57186; |
WB Predicted band size | 250kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human,Mouse,Rat |
Immunogen | KLH-conjugated synthetic peptide encompassing a sequence within the center region of human RALGAPA2. |
Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于p22抗体的3篇参考文献及其摘要概括:
1. **文献名称**: *"Anti-p22 antibodies in antineutrophil cytoplasmic antibody-associated vasculitis: A multicenter study"*
**作者**: Rothschild PR, et al.
**摘要**: 该研究探讨了抗p22抗体在ANCA(抗中性粒细胞胞质抗体)相关血管炎中的临床意义,发现其在部分患者中可作为疾病活动的生物标志物,并与肾脏受累相关。
2. **文献名称**: *"p22phox as a critical component of NADPH oxidase in hepatocellular carcinoma progression"*
**作者**: Hirota S, et al.
**摘要**: 研究揭示了p22phox蛋白在肝癌细胞中通过NADPH氧化酶复合体促进活性氧(ROS)生成,进而驱动肿瘤侵袭和转移,抗p22抗体可用于靶向该通路。
3. **文献名称**: *"Autoantibodies against p22 phagocyte oxidase in systemic sclerosis"*
**作者**: Terrier B, et al.
**摘要**: 发现系统性硬化症患者血清中存在抗p22抗体,可能与血管损伤和纤维化病理过程相关,提示其在自身免疫反应中的潜在作用。
4. **文献名称**: *"p22phox-dependent ROS production in microbial killing by neutrophils"*
**作者**: Dahan K, et al.
**摘要**: 通过抗p22抗体阻断实验,证实p22phox是中性粒细胞NADPH氧化酶功能的核心组分,对病原体清除中的活性氧生成至关重要。
(注:以上文献信息为模拟示例,实际引用需核对真实数据库。)
The p22 antibody targets the p22phox protein, a critical subunit of the NADPH oxidase complex, which plays a central role in generating reactive oxygen species (ROS). This 22-kDa protein, encoded by the *CYBA* gene, forms a heterodimer with gp91phox (NOX2) to create cytochrome b558. the membrane-bound core of the NADPH oxidase. Primarily expressed in phagocytes, this complex is essential for microbial killing via the "respiratory burst." Mutations in *CYBA* disrupt oxidase assembly, leading to chronic granulomatous disease (CGD), a rare immunodeficiency disorder characterized by recurrent infections.
p22phox also interacts with other NOX isoforms (e.g., NOX1. NOX3. NOX4), linking it to ROS-mediated signaling in non-phagocytic cells, including endothelial, vascular smooth muscle, and fibroblasts. Dysregulated ROS production involving p22phox is implicated in cardiovascular diseases (e.g., hypertension, atherosclerosis), inflammation, and cancer.
Anti-p22 antibodies are vital tools in research and diagnostics. They enable detection of p22phox expression via Western blotting, immunofluorescence, or flow cytometry, aiding in CGD diagnosis by identifying protein deficiencies. Additionally, these antibodies help study ROS-related pathways in cellular models, clarifying p22phox's role in oxidative stress and disease mechanisms. Their specificity ensures accurate assessment of NADPH oxidase activity and subunit interactions, making them indispensable for both basic research and clinical applications.
×